ASH1L-AS1

Across TCGA pan-cancer cohorts, ASH1L-AS1 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated ASH1L-AS1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ASH1L-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ASH1L-AS1 expression acts as an unfavorable survival marker, although some lineages such as CESC and SKCM show a favorable association.

ACC, THCA, and KIRP are the cancer types where ASH1L-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.197	0.700	<.001	102	view →
THCA	OS	Median	All	0.956	0.993	.002	58	view →
KIRP	DFS	Tertile	IV	0.037	0.812	.001	51	view →
LIHC	DFS	Quartile	All	0.397	0.602	<.001	45	view →
CESC	OS	Median	II,III,IV	0.887	0.602	<.001	42	view →
SKCM	OS	Median	IV	0.839	0.285	<.001	34	view →
ESCA	DFS	Tertile	II,III,IV	0.309	0.606	<.001	34	view →
UCEC	DFS	Tertile	All	0.769	0.896	<.001	32	view →
UVM	DFS	Quartile	III,IV	0.081	1.000	.006	29	view →
LUSC	OS	Quartile	II,III,IV	0.708	0.507	.008	23	view →
PRAD	DFS	Quartile	All	0.717	0.895	.005	16	view →
KIRC	DFS	Median	IV	0.513	0.712	.009	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

ASH1L-AS1–ACC (DFS)

Open the ACC breakdown →